Skip to main content
AprilBio Co.,Ltd. logo

AprilBio Co.,Ltd. — Investor Relations & Filings

Ticker · 397030 ISIN · KR7397030008 KO Professional, scientific and technical activities
Open in API
Filings indexed 152 across all filing types
Latest filing 2021-03-31 Audit Report / Informat…
Country KR South Korea
Listing KO 397030

About AprilBio Co.,Ltd.

http://www.aprilbio.com/en/

AprilBio is a biotechnology company that develops innovative biologic drugs, including therapeutic antibodies and recombinant proteins. The company's core is its proprietary SAFA (anti-Serum Albumin Fab-Associated) platform technology, which utilizes an albumin-binding antibody fragment to create long-acting therapeutics. This platform is designed to enhance the efficacy, safety, and plasma half-life of drug candidates while minimizing adverse effects. AprilBio's research and development pipeline focuses on addressing unmet medical needs in therapeutic areas such as autoimmune diseases, oncology, and other inflammatory and rare diseases. The company advances new drug candidates through early clinical development stages for potential technology transfer.

Recent filings

Filing Released Lang Actions
[기재정정]감사보고서 (2019.12)
Audit Report / Information Classification · 100% confidence The document is a 'Correction Report' (정정신고) for an Audit Report (감사보고서) originally submitted in 2020. It contains detailed financial statements (Balance Sheet, Income Statement, Statement of Changes in Equity, Cash Flow Statement) and notes to the financial statements for the fiscal year 2019. Since it is a formal audit report document (including the auditor's opinion and financial statements) that has been corrected, it falls under the category of Audit Report / Information. FY 2019
2021-03-31 Korean
감사보고서 (2019.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'AprilBio' (주식회사 에이프릴바이오) for the fiscal year ending December 31, 2019. It includes the independent auditor's report, financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes. This is a comprehensive financial document, not an announcement or a summary, and fits the definition of an Audit Report/Information (AR) as it provides the results of the audit and the financial statements. FY 2019
2020-04-02 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.